Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Markolf Hanefeld, Gary A. Herman, Mei Wu, Carolyn Mickel, Matilde Sanchez, Peter P. Stein, on behalf of the Sitagliptin Study 014 investigators
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2129578585
